Your browser doesn't support javascript.
loading
Long-Term Selegiline Monotherapy for the Treatment of Early Parkinson Disease.
Mizuno, Yoshikuni; Hattori, Nobutaka; Kondo, Tomoyoshi; Nomoto, Masahiro; Origasa, Hideki; Takahashi, Ryosuke; Yamamoto, Mitsutoshi; Yanagisawa, Nobuo.
Afiliação
  • Mizuno Y; Department of Neurology, Juntendo University School of Medicine, Tokyo.
  • Hattori N; Department of Neurology, Juntendo University School of Medicine, Tokyo.
  • Kondo T; Rehabilitation Hananoie Hospital, Tochigi.
  • Nomoto M; Department of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, Ehime.
  • Origasa H; Department of Biostatistics and Clinical Epidemiology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama.
  • Takahashi R; Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto.
  • Yamamoto M; Takamatsu Neurology Clinic, Takamatsu.
  • Yanagisawa N; All Japan Labor Welfare Foundation, Tokyo, Japan.
Clin Neuropharmacol ; 42(4): 123-130, 2019.
Article em En | MEDLINE | ID: mdl-31045589

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Selegilina / Inibidores da Monoaminoxidase / Antiparkinsonianos Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Neuropharmacol Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Selegilina / Inibidores da Monoaminoxidase / Antiparkinsonianos Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Neuropharmacol Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos